GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Konruns Pharmaceutical Co Ltd (SHSE:603590) » Definitions » Days Sales Outstanding

Beijing Konruns Pharmaceutical Co (SHSE:603590) Days Sales Outstanding

: 102.16 (As of Sep. 2023)
View and export this data going back to 2018. Start your Free Trial

Beijing Konruns Pharmaceutical Co's average Accounts Receivable for the three months ended in Sep. 2023 was ¥301.4 Mil. Beijing Konruns Pharmaceutical Co's Revenue for the three months ended in Sep. 2023 was ¥269.2 Mil. Hence, Beijing Konruns Pharmaceutical Co's Days Sales Outstanding for the three months ended in Sep. 2023 was 102.16.

The historical rank and industry rank for Beijing Konruns Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SHSE:603590' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.44   Med: 39.42   Max: 107.54
Current: 98.71

During the past 10 years, Beijing Konruns Pharmaceutical Co's highest Days Sales Outstanding was 107.54. The lowest was 7.44. And the median was 39.42.

SHSE:603590's Days Sales Outstanding is ranked worse than
65.16% of 887 companies
in the Biotechnology industry
Industry Median: 72.76 vs SHSE:603590: 98.71

Beijing Konruns Pharmaceutical Co's Days Sales Outstanding increased from Sep. 2022 (93.60) to Sep. 2023 (102.16).


Beijing Konruns Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Beijing Konruns Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Konruns Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.99 74.91 88.20 92.11 107.54

Beijing Konruns Pharmaceutical Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 93.60 80.13 147.80 90.37 102.16

Competitive Comparison

For the Biotechnology subindustry, Beijing Konruns Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Konruns Pharmaceutical Co Days Sales Outstanding Distribution

For the Biotechnology industry and Healthcare sector, Beijing Konruns Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Beijing Konruns Pharmaceutical Co's Days Sales Outstanding falls into.



Beijing Konruns Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Beijing Konruns Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (233.99 + 276.722) / 2 ) / 866.726*365
=255.356 / 866.726*365
=107.54

Beijing Konruns Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding (Q: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (307.788 + 295.008) / 2 ) / 269.201*365 / 4
=301.398 / 269.201*365 / 4
=102.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Konruns Pharmaceutical Co  (SHSE:603590) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Beijing Konruns Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Beijing Konruns Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Konruns Pharmaceutical Co (SHSE:603590) Business Description

Traded in Other Exchanges
N/A
Address
No. 11 Xingsheng South Road, Economic Development Zone, Miyun District, Beijing, CHN
Beijing Konruns Pharmaceutical Co Ltd is a Chinese pharmaceutical company. It is engaged in the research and development of innovative drugs, and is oriented to clinical needs.

Beijing Konruns Pharmaceutical Co (SHSE:603590) Headlines

No Headlines